The Nordic EMBL Partnership for Molecular Medicine, which includes the Danish Research Institute for Translational Neuroscience (DANDRITE, www.dandrite.au.dk), Institute for Molecular Medicine Finland (FIMM, www.fimm.fi), Laboratory for Molecular Infection Medicine Sweden (MIMS, www.mims.umu.se), and Centre for Molecular Medicine Norway (NCMM, www.ncmm.uio.no) is dedicated to research excellence in molecular medicine, life science research that investigates the molecular basis of disease and explores molecular and genetic based treatments. Aiming to combine complementary strengths in the Partnership, each institute brings a unique set of expertise, skills, and facilities encompassing the recognized research strengths of the EMBL. The Partnership provides access to scientific infrastructure as well as clinical materials, networks, and training activities and adopts the EMBL model for international recruitment and scientific reviews.
The Nordic EMBL Partnership is now seeking outstanding international candidates for the position of
PhD Students in Molecular Medicine & Bioinformatics
FIMM: Helsinki, Finland
> Molecular Medicine & Bioinformatics
Institute for Molecular Medicine Finland (FIMM) is an international research institute focusing on human genomics and personalized medicine. FIMM integrates molecular medicine research and technology centre and biobanking infrastructure promoting translational research in grand challenge projects, such as the impact of genome information from the Finnish population in personalized health and medicine, individualized cancer medicine, and novel imaging-based diagnostics. In the areas of bioinformatics and computational systems biology, FIMM collaborates with Helsinki Institute for Information Technology HIIT (www.hiit.fi). FIMM and HIIT work together with University of Helsinki and Aalto University doctoral programs to provide excellent research training toward a PhD degree.
Applications are currently sought in the areas 1) molecular medicine and 2) bioinformatics or computational systems biology. Details can be found at www.fimm.fi/open-positions.
DANDRITE: Aarhus, Denmark
> Translational Neuroscience
DANDRITE is an interdisciplinary research institute of neuroscience at Aarhus University, combining structural, mechanistic, cell biological, translational, and clinical research of neuronal networks and transmembrane communication in health and disease of nervous systems. The aim is to investigate the molecular and cellular mechanism underlying behaviour and sensory functions, and to reveal pathophysiological mechanisms and new intervention strategies of neurological and psychiatric disorders. The research encompasses molecular, cellular and transgenic animal models with links to clinical research, and integrates technologies spanning from membrane protein crystallography and cryoEM to advanced imaging, neuronal circuitry analysis, behavioural models, and stem cells.
Applications with deadlines four times per year are sought for the PhD degree program Molecular Medicine. Details can be found at dandrite.au.dk/job-study-opportunities/phd-studies/.
MIMS: Umeå, Sweden
> Molecular Infection Medicine
MIMS aims to strengthen Swedish research and enhance the dynamic field of molecular medicine by promoting career opportunities for young scientists. MIMS operates within the Umeå Centre for Microbial Research (UCMR, www.ucmr.umu.se) that includes researchers in the field of molecular and clinical microbiology, molecular biology, chemistry, and physics. MIMS and UCMR are affiliated with the Faculties of Medicine and Science and Technology and are closely connected to the university hospital (Norrlands University Hospital).
Information on open positions is posted regularly at: www.mims.umu.se/jobs-fellowships.html.
NCMM: Oslo, Norway
> Molecular Medicine
NCMM was established in 2008 with an overall objective to conduct cutting edge research in molecular medicine and facilitate translation of discoveries in basic medical research into clinical practice. NCMM focuses particularly on disease mechanisms of non-communicable disease such as cancer, immune disorders, cardiovascular and CNS-related diseases. NCMM develops and adapts technologies for personalized medical applications and has unravelled new diagnostic methods and drug targets.
Information on open position is posted regularly at:: www.ncmm.uio.no/open-positions.
Further details:
http://www.nature.com